A lively debate ensues with day-traders chasing popular household names, pushing the stock market up, claim sceptics. Not so, argue the bulls, who point out that US technology is helping…
Much of the vaccine focus is currently on existing, stage three trials (Moderna, Oxford University etc). But adenovirus-based vaccines have been shown to elicit strong immune responses. This is promising….
As the US stock market edges past the February 19th peak (3386.2), the focus may switch to the global laggards. The US has at times struggled to deal with Covid-19,…
Fatalities from Covid-19 remain low in relation to the peak (2,749, April 21st) and low given the jump in infections recorded last month. The Treasury market is focussed on the…
The payroll report for July was mixed. The recovery to full employment will be long, slow and arduous. The July Challenger layoff survey showed a rise in job cuts. Nevertheless,…
Big tech has delivered. Apple, Amazon, Facebook and Alphabet all announced very strong profit numbers last week. Regulatory scrutiny and the virus pandemic have failed to dent earnings. At the…